Four things to know:
1. Sanofi raised the price of its three main insulin brands between 4.4 percent to 5.2 percent last week.
2. Novo Nordisk hiked the price of its insulin products just shy of 5 percent on Jan. 8.
3. The insulin price hikes come as anger over insulin prices in the U.S. swells and as political pressure mounts to lower the cost of prescription medicines.
4. “Diabetic patients who require insulin to remain healthy, and in some cases stay alive, were dealt a blow with the latest price increases,” said Michael Rea, founder and chief executive of RX Savings Solutions, a company that makes software for pricing prescription drugs.
Read the full report here.
More articles on pharmacy:
Hospital-owned drug company attracts 12 more health systems
How nurses are becoming integral to pharma marketing: 7 notes
4 tips for managing drug spend from Alameda Health System’s Dr. Yi-Chih Peng
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
